EUVIMEDSkopri EUVIMED
CrossrefKarta ta’ informazzjoni

Update on current TAVI technology, indications, screening, and outcomes

A. Halapas, M. Chrissoheris, N. Bouboulis, J. Nicolaou, S. Pattakos, K. Spargias

Continuing Cardiology Education · 2016

DOI: 10.1002/cce2.20 ↗
AstrattDettalji biblijografiċi

Astratt

Abstract Transcatheter aortic valve replacement ( TAVI ) is an established treatment for inoperable patients or patients at high surgical risk with severe aortic stenosis. Herein, we illustrate the key design features of the main new generation devices that are entering contemporary clinical practice, the labeled and off‐labeled indications, the basic principles of screening process, and the clinical outcomes of the TAVI procedure. Answer questions and earn CME: https://wileyhealthlearning.com/Activity2/4193543/Activity.aspx

Għarfien li jaqbel max-xogħol tiegħek.

Minn bidu b’xejn u riċerka personali tal-letteratura sal-Research Suite sħiħa.

Ara t-tariffi →

Il-full texts kollha tal-pubblikaturi huma inklużi?

Le. Ir-referenzi biblijografiċi, l-astratti u t-testi sħaħ huma kontenuti differenti. Jekk test sħiħ huwiex disponibbli jiddependi mis-sors, Open Access u l-liċenzji eżistenti tiegħek. Pjan ta’ EUVIMED ma jissostitwix drittijiet addizzjonali tal-pubblikaturi.

Ara t-tariffi →